BioCatch Stock
Cybersecurity
Sign up today and learn more about BioCatch Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About BioCatch Stock
BioCatch offers a range of behavioral authentication and threat detection solutions for web and mobile applications. Available as a cloud-based solution, BioCatch collects and analyzes more than 2000 cognitive parameters to generate unique user profiles. Organizations use the platform to continuously authenticate users during their online sessions, protecting against cyber threats and fraudulent activity, such as account takeover and RAT-in-the-Browser (RitB), remote access, and automated accounting manipulation.
Investors
Bain Capital Tech Opportunities
OurCrowd
JANVEST Capital Partners
Maverick Ventures
Devoted Health, Cityblock Health, Collective Health, One Medical, LTK, Snapdocs, Heap, Bungalow, BioCatch, Caribou Biosciences
Funding History
| September 2011 | $760K |
|---|---|
| June 2012 | $1.7M |
| April 2020 | $21.0M |
| April 2020 | $28.1M |
| April 2020 | $3.0M |
| August 2020 | $8.3M |
| August 2020 | $2.0M |
| August 2020 | $20.4M |
| August 2020 | $0 |
Management
Chief Executive Officer
Howard Edelstein
Co-Founder & Chief Technology Officer
Avi Turgeman
Co-Founder & Chief Cyber Officer
Uri Rivner
Chief Financial Officer
Greg Stockett
Chief Operating Officer
Gadi Mazor
Chief Revenue Officer
Bill Sytsma
Press
prnewswire - Apr, 10 2024
BioCatch Releases Comprehensive Analysis of Banking-Fraud and Financial-Crime Trends in Europefintechfutures - Apr, 8 2024
BioCatch and COMM Partner to Execute Award-Winning Account-Based Marketing Campaign, Achieving a Remarkable 63% Increase in Prospect Engagementtimesofindia - Apr, 5 2024
BioCatch report on digital banking fraud trends in Indiacalcalistech - Apr, 5 2024
Australian investment giant Macquarie acquires $32 million-worth of BioCatch sharesEquityZen Recognized As:
